Read more about Dr Reddy's to manufacture baricitinib for Covid -19 treatment in India on Business Standard. Dr. Reddy's Laboratories announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly for the manufacture commercialisation of baricitinib in India